Our Services
Medical Information
Helpful Resources
Published on: 5/21/2026
Pulmonary function tests offer clear, objective measurements of airflow obstruction, air trapping, and gas diffusion in severe asthma, helping to classify disease severity and tailor treatments such as inhaled steroids or biologic therapies. Regular monitoring with spirometry, lung volumes, diffusion capacity, and challenge tests can catch early declines in lung function before symptoms worsen.
There are numerous important details on interpreting results, understanding test limitations, and deciding next steps in your care below.
Understanding Pulmonary Function Tests for Severe Asthma: What the Science Shows
Pulmonary function tests (PFTs) are key tools in assessing how well your lungs work. For people with severe asthma, these tests help doctors measure airway obstruction, track disease progression, and tailor treatments. This guide breaks down the science behind PFTs in simple language, explains what the numbers mean, and shows why regular testing matters.
Why Pulmonary Function Tests Matter in Severe Asthma
• Objective measurement: PFTs give clear, repeatable data on lung function.
• Disease classification: Results help classify asthma severity (mild, moderate, severe).
• Treatment guidance: Doctors use trends in PFTs to adjust medications—especially inhaled steroids and biologics.
• Monitoring: Regular testing can catch early decline in lung function before symptoms worsen.
Even if you manage your asthma well, you might consider using a free Bronchial Asthma symptom checker to gain additional insights into your symptoms and lung health between doctor visits.
Spirometry is the foundation of PFTs. It measures how much air you can exhale and how quickly.
In severe asthma:
Asthma can lead to air trapping—difficulty expelling all the air from the lungs. Measuring lung volumes requires specialized equipment:
Elevated RV or RV/TLC alerts clinicians to hyperinflation, which can cause shortness of breath and reduce exercise tolerance.
DLCO tests how well oxygen moves from the air sacs into your blood. While asthma primarily affects airways, long-standing or severe disease can change airway walls and surrounding tissue, occasionally altering DLCO.
If baseline spirometry is normal but asthma is still suspected, a challenge test can provoke airway narrowing under controlled conditions.
Obstructive Pattern
Reversibility
Severity Classification
Based on percent predicted FEV₁ (adjusted for age, sex, height, ethnicity):
Air Trapping & Hyperinflation
• Medication Adjustment: Persistent obstruction or lack of reversibility may prompt increasing inhaled corticosteroids, adding long-acting bronchodilators, or considering biologic therapies.
• Monitoring Treatment Response: Regular spirometry (every 3–12 months) shows whether lung function stabilizes, improves, or worsens.
• Preventing Exacerbations: Detecting gradual decline in FEV₁ can lead to early intervention, reducing hospitalizations and emergency visits.
• Assessing Safety for Activities: For athletes or highly active individuals, exercise challenge tests ensure safe participation in sports.
While invaluable, PFTs have limits:
Pulmonary function tests provide crucial data, but they're part of a comprehensive care plan. Speak to a doctor if you experience:
If you're experiencing new or worsening respiratory symptoms, an AI-powered Bronchial Asthma symptom checker can help you better understand what you're experiencing and prepare for your doctor's appointment.
Remember, only a healthcare professional can interpret your results in the context of your overall health. If you have life-threatening or serious symptoms, seek immediate medical attention.
Pulmonary function tests empower you and your healthcare team to understand and manage severe asthma effectively. Regular testing, honest symptom reporting, and close collaboration with your doctor will help keep your lungs as healthy as possible. Speak to your physician about scheduling or interpreting PFTs—and never hesitate to seek urgent care for sudden or severe breathing problems.
(References)
* Am J Physiol Lung Cell Mol Physiol. 2022 May 1;322(5):L663-L677. doi: 10.1152/ajplung.00032.2022. Epub 2022 Feb 23. PMID: 35189737.
* J Asthma. 2023 Dec;60(12):2478-2490. doi: 10.1080/02770903.2023.2173872. Epub 2023 Feb 1. PMID: 36728362.
* J Allergy Clin Immunol Pract. 2019 Mar;7(3):792-799. doi: 10.1016/j.jacip.2018.12.016. Epub 2019 Jan 15. PMID: 30737604.
* J Clin Med. 2021 May 26;10(11):2303. doi: 10.3390/jcm10112303. PMID: 34127976; PMCID: PMC8197793.
* Breathe (Sheff). 2019 Dec;15(4):e101-e110. doi: 10.1183/20734735.0210-2019. PMID: 31835732; PMCID: PMC6909890.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.